Polymorphisms within the


Journal

Infection and immunity
ISSN: 1098-5522
Titre abrégé: Infect Immun
Pays: United States
ID NLM: 0246127

Informations de publication

Date de publication:
23 03 2020
Historique:
received: 22 11 2019
accepted: 10 01 2020
pubmed: 23 1 2020
medline: 9 7 2020
entrez: 23 1 2020
Statut: epublish

Résumé

Invasive aspergillosis (IA) is a life-threatening infection that affects an increasing number of patients undergoing chemotherapy or allo-transplantation, and recent studies have shown that genetic factors contribute to disease susceptibility. In this two-stage, population-based, case-control study, we evaluated whether 7 potentially functional single nucleotide polymorphisms (SNPs) within the

Identifiants

pubmed: 31964743
pii: IAI.00882-19
doi: 10.1128/IAI.00882-19
pmc: PMC7093133
pii:
doi:

Substances chimiques

ARNT2 protein, human 0
Basic Helix-Loop-Helix Transcription Factors 0
CX3C Chemokine Receptor 1 0
CX3CR1 protein, human 0
Aryl Hydrocarbon Receptor Nuclear Translocator 138391-32-9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 American Society for Microbiology.

Références

Science. 2002 Jun 21;296(5576):2225-9
pubmed: 12029063
Med Mycol. 2013 Nov;51(8):818-25
pubmed: 23862689
Annu Rev Immunol. 2014;32:403-32
pubmed: 24655296
Immunol Lett. 2007 Mar 15;109(1):76-82
pubmed: 17321603
J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):527-31
pubmed: 16284527
Clin Infect Dis. 2008 Jun 15;46(12):1813-21
pubmed: 18462102
Biochem J. 2003 Jul 15;373(Pt 2):547-58
pubmed: 12729461
Blood. 2012 Jan 26;119(4):967-77
pubmed: 22147891
Infect Immun. 2015 Dec 14;84(3):643-57
pubmed: 26667837
Annu Rev Pharmacol Toxicol. 2000;40:519-61
pubmed: 10836146
Biol Blood Marrow Transplant. 2007 Oct;13(10):1192-200
pubmed: 17889356
Ann N Y Acad Sci. 2005 Dec;1062:95-103
pubmed: 16461792
Curr Clin Microbiol Rep. 2016 Jun;3(2):81-91
pubmed: 27547700
Med Mycol. 2011 Apr;49 Suppl 1:S7-S12
pubmed: 20718606
Infect Immun. 2015 Mar;83(3):958-65
pubmed: 25547797
Nat Genet. 2013 Oct;45(10):1238-1243
pubmed: 24013639
Blood. 2010 Dec 9;116(24):5394-402
pubmed: 20807886
J Clin Invest. 2013 Dec;123(12):5035-51
pubmed: 24177428
Cancer Res. 2008 Mar 15;68(6):1715-22
pubmed: 18339851
Clin Infect Dis. 2010 Jun 15;50(12):1559-67
pubmed: 20450350
Science. 2000 Mar 24;287(5461):2274-7
pubmed: 10731151
Blood. 2008 Jan 15;111(2):534-6
pubmed: 17957030
N Engl J Med. 2001 Apr 5;344(14):1099-100
pubmed: 11291675
Soc Neurosci. 2014;9(4):378-86
pubmed: 24635660
Science. 2006 Jan 6;311(5757):83-7
pubmed: 16322423
Clin Infect Dis. 1998 Mar;26(3):753-5
pubmed: 9524855
PLoS One. 2012;7(2):e32273
pubmed: 22384201
Hum Immunol. 2007 Jan;68(1):41-50
pubmed: 17207711
Int J Immunopathol Pharmacol. 2010 Apr-Jun;23(2):423-36
pubmed: 20646338
PLoS One. 2010 May 18;5(5):e10693
pubmed: 20502693
Clin Infect Dis. 2005 Jul 1;41(1):52-9
pubmed: 15937763
J Infect Dis. 2011 Mar 1;203(5):736-43
pubmed: 21242599
Blood. 2002 Dec 15;100(13):4358-66
pubmed: 12393425
J Immunol. 2000 Dec 15;165(12):6975-83
pubmed: 11120824
Exp Hematol. 2009 Sep;37(9):1022-9
pubmed: 19539691
Am J Infect Control. 2011 May;39(4):e15-20
pubmed: 20961657
Eur Respir J. 2003 Apr;21(4):582-8
pubmed: 12762339
J Allergy Clin Immunol. 2017 Sep;140(3):867-870.e9
pubmed: 28389392
Crit Care. 2015 Jan 12;19:7
pubmed: 25928694
Med Sci (Paris). 2016 Mar;32(3):260-6
pubmed: 27011244
J Infect. 2012 Nov;65(5):453-64
pubmed: 22898389
Cell. 1997 Nov 14;91(4):521-30
pubmed: 9390561
J Immunol. 2014 Feb 15;192(4):1661-70
pubmed: 24403534
N Engl J Med. 2008 Oct 23;359(17):1766-77
pubmed: 18946062
Multidiscip Respir Med. 2013 Sep 04;8(1):59
pubmed: 24135224
PLoS Pathog. 2013;9(8):e1003434
pubmed: 23950708
Toxicol Sci. 2008 May;103(1):191-206
pubmed: 18096572
J Clin Immunol. 2008 Sep;28(5):473-85
pubmed: 18484169
Nature. 2014 Jul 10;511(7508):184-90
pubmed: 24930766
Chem Biol Interact. 1996 Mar 25;100(2):97-112
pubmed: 8646792
Thorax. 1991 Jan;46(1):15-20
pubmed: 1871691
Genes Dev. 1999 Jul 1;13(13):1742-53
pubmed: 10398686
Immunology. 2011 Apr;132(4):567-77
pubmed: 21255011
N Engl J Med. 1991 Mar 7;324(10):654-62
pubmed: 1994248
Haematologica. 2006 Jul;91(7):986-9
pubmed: 16757415
J Infect Dis. 2005 Jun 1;191(11):1971-80
pubmed: 15871132

Auteurs

C B Lupiañez (CB)

Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.
Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.
Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.

M Martínez-Bueno (M)

Genomic Medicine Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.

J M Sánchez-Maldonado (JM)

Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.
Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.

J Badiola (J)

Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.
Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.

C Cunha (C)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
ICVS/3B's, PT Government Associate Laboratory, Braga, Portugal.

J Springer (J)

Universitätsklinikum Würzburg, Medizinische Klinik II, Würzburg, Germany.

M Lackner (M)

Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.

J Segura-Catena (J)

Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.
Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.
Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.

L M Canet (LM)

Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.
Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.

L Alcazar-Fuoli (L)

Mycology Reference Laboratory, Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Madrid, Spain.

M A López-Nevot (MA)

Immunology Department, Virgen de las Nieves University Hospital, Granada, Spain.

L Fianchi (L)

Istituto di Ematologia, Università Cattolica del S. Cuore, Rome, Italy.

J M Aguado (JM)

Unit of Infectious Diseases, Hospital Universitario "12 de Octubre," Instituto de Investigación Hospital "12 de Octubre" (i+12), Madrid, Spain.

L Pagano (L)

Istituto di Ematologia, Università Cattolica del S. Cuore, Rome, Italy.

E López-Fernández (E)

Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.
Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.
Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.

M Alarcón-Riquelme (M)

Genomic Medicine Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.

L Potenza (L)

Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Policlinico, Modena, Italy.

S M Gonçalves (SM)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
ICVS/3B's, PT Government Associate Laboratory, Braga, Portugal.

M Luppi (M)

Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Policlinico, Modena, Italy.

L Moratalla (L)

Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.
Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.
Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.

C Solano (C)

Hematology Department, Hospital Clinico Universitario-INCLIVA, University of Valencia, Spain.

A Sampedro (A)

Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.
Department of Microbiology, Virgen de las Nieves University Hospital, Granada, Spain.

P González-Sierra (P)

Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.
Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.
Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.

M Cuenca-Estrella (M)

Mycology Reference Laboratory, Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Madrid, Spain.

K Lagrou (K)

Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium.
National Reference Center for Medical Mycology, University Hospitals Leuven, Leuven, Belgium.

J A Maertens (JA)

Department of Hematology, University Hospitals Leuven, Leuven, Belgium.

C Lass-Flörl (C)

Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.

H Einsele (H)

Universitätsklinikum Würzburg, Medizinische Klinik II, Würzburg, Germany.

L Vazquez (L)

Hematology Department, University Hospital of Salamanca, Salamanca, Spain.

J Loeffler (J)

Universitätsklinikum Würzburg, Medizinische Klinik II, Würzburg, Germany.

R Ríos-Tamayo (R)

Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.
Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.
Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.

A Carvalho (A)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
ICVS/3B's, PT Government Associate Laboratory, Braga, Portugal.

M Jurado (M)

Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.
Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.
Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.

J Sainz (J)

Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain juan.sainz@genyo.es.
Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.
Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH